Detalhe da pesquisa
1.
Drug development for major chronic health conditions-aligning with growing public health needs: Proceedings from a multistakeholder think tank.
Am Heart J
; 270: 23-43, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38242417
2.
Framework of the Strengths and Challenges of Clinically Integrated Trials: An Expert Panel Report.
Am Heart J
; 2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38795793
3.
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
Clin Infect Dis
; 77(12): 1635-1643, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37435958
4.
Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med
; 382(20): 1883-1893, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32222134
5.
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.
J Card Fail
; 29(4): 448-458, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634811
6.
Classification of Heart Failure Events by Severity: Insights From the VICTORIA Trial.
J Card Fail
; 29(8): 1113-1120, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331690
7.
CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research.
Eur Heart J
; 43(37): 3578-3588, 2022 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208161
8.
Hemoglobin and Clinical Outcomes in the Vericiguat Global Study in Patients With Heart Failure and Reduced Ejection Fraction (VICTORIA).
Circulation
; 144(18): 1489-1499, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34432985
9.
Medical Therapy During Hospitalization for Heart Failure With Reduced Ejection Fraction: The VICTORIA Registry.
J Card Fail
; 28(7): 1063-1077, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35301107
10.
Enabling patient-reported outcome measures in clinical trials, exemplified by cardiovascular trials.
Health Qual Life Outcomes
; 19(1): 164, 2021 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120618
11.
Drug Development in Kidney Disease: Proceedings From a Multistakeholder Conference.
Am J Kidney Dis
; 76(6): 842-850, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32768631
12.
Psychometric properties of the Japanese version of the Kansas City Cardiomyopathy Questionnaire in Japanese patients with chronic heart failure.
Health Qual Life Outcomes
; 18(1): 236, 2020 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32680513
13.
Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.
JAMA
; 324(15): 1512-1521, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33079152
14.
Clinical Implications of Negatively Adjudicated Heart Failure Events: Data From the VICTORIA Study.
Circulation
; 147(8): 694-696, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36802884
15.
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.
Eur Heart J
; 38(15): 1119-1127, 2017 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369340
16.
Novel sGC Stimulators and sGC Activators for the Treatment of Heart Failure.
Handb Exp Pharmacol
; 243: 225-247, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27900610
17.
Improving cardiovascular clinical trials conduct in the United States: recommendation from clinicians, researchers, sponsors, and regulators.
Am Heart J
; 169(3): 305-14, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25728719
18.
Clinical trials in hospitalized heart failure patients: targeting interventions to optimal phenotypic subpopulations.
Heart Fail Rev
; 20(4): 393-400, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25894076
19.
Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction: The SOCRATES-REDUCED Randomized Trial.
JAMA
; 314(21): 2251-62, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26547357
20.
Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
Circulation
; 128(5): 502-11, 2013 Jul 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-23775260